Pramocaine or pramoxin or pramoxine

This classification denotes an anesthetic agent with the molecular formula C17H27NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 068X84E056, chemically known as morpholine, 4-(3-(p-butoxyphenoxy)propyl)- but generally known as pramocaine, which bears US NIH Compound Identifier 4886. European Medicines Agency schedules Pramocaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09994MIG. The term PRAMOCAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules pramocaine in its Anatomical Therapeutic Chemical (ATC) Classification. PRAMOCAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2.